Agile Therapeutics, a biotech developing wearable prescription contraceptive patches, filed on Monday with the SEC to raise up to $69 million in an initial public offering. The Princeton, NJ-based company, which was founded in 1997, plans to list on the NASDAQ under the symbol AGRX. RBC Capital Markets and William Blair are the joint bookrunners on the deal. No pricing terms were disclosed.
